The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Long‐chain n‐3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease
Open accessAbstract
Evidence from observational studies, prospective cohort studies and randomized clinical intervention studies indicate that moderate doses of long‐chain n‐3 polyunsaturated fatty acids (LC n‐3 PUFA) significantly decrease risk of fatal coronary heart disease (CHD). Higher doses and longer duration of intervention may also protect from non‐fatal CHD events. The exact mechanisms through which LC n‐3 PUFA has an effect on CHD are not well established but may include a decrease in fasting and postprandial triacylglycerol levels, a decrease in arrhythmias, modulation of platelet aggregation and decreased synthesis of pro‐inflammatory agents. The mechanistic relation between LC n‐3 PUFA and inflammation has attracted great interest, and in vitro studies have revealed that these fatty acids decrease endothelial activation, affect eicosanoid metabolism (including epoxygenation pathways) and induce inflammatory resolution. However, the effects of LC n‐3 PUFA on established biomarkers of inflammation and endothelial activation in vivo are not strong. Consequently we need new and more sensitive and systemic biomarkers to reveal the effects of LC n‐3 PUFA on localized inflammatory processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, reduction in atherosclerosis in animal models or humans by administration of OM3FAs has not been convincingly demonstrated [8, 11].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,796
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Cited by
Sorted by citations
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Bioavailability of bioactive food compounds: a challenging journey to bioefficacy.
Rein, M. J., Renouf, M., Cruz-Hernandez, C., Actis-Goretta, L., Thakkar, S. K., & Pinto, M. I. D. S. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04425.x · Cited by 763
Foods, Nutrients, and Dietary Patterns: Interconnections and Implications for Dietary Guidelines
Tapsell, L. C., Neale, E. P., Satija, A., & Hu, F. B. (2016) · Advances in Nutrition · doi:10.3945/an.115.011718 · Cited by 744
“Although long-chain n–3 PUFAs may modulate CVD risk through the reduction of plasma TGs and platelet aggregation, and via anti-inflammatory effects (48), preliminary evidence comparing consumption of fish with long-chain n–3 PUFA supplements suggests that consumption of the whole food may deliver additional benefits n…”
BackgroundLayé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
“3) (De Roos et al., 2009; Arita, 2012).”
(n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
Mozaffarian, D., & Wu, J. H. Y. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.149633 · Cited by 368
“, PG-E2, leukotriene-B4, thromboxaneB2) (57) as well as circulating concentrations of epoxyeicosatrienoic acids (58).”
BackgroundModifiable risk factors in periodontitis: at the intersection of aging and disease
Reynolds, M. A. (2013) · Periodontology 2000 · doi:10.1111/prd.12047 · Cited by 233
Heshmati, J., Morvaridzadeh, M., Maroufizadeh, S., Akbari, A., Yavari, M., Amirinejad, A., Maleki‐Hajiagha, A., & Sepidarkish, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104462 · Cited by 211
Zuñiga, J., Cancino, M., Medina, F., Varela, P., Vargas, R., Tapia, G., Videla, L., & Fernandez, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028502 · Cited by 199
Echeverría, F., Ortíz, M., Valenzuela, R., & Videla, L. A. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.10.001 · Cited by 211
I Diretriz sobre o consumo de Gorduras e Saúde Cardiovascular
Santos, R., Gagliardi, A., Xavier, H. T., Magnoni, C., Cassani, R., Lottenberg, A., Filho, A. C., Araújo, D., Cesena, F., Alves, R., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s003 · Cited by 211
Oscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158
“Aside from effects on TG-rich lipoproteins, OM3FAs may reduce CV risk via other mechanisms such as effects on arrhythmias and inflammation, as reviewed by de Roos and colleagues [11].”
BackgroundHarris, W. S., Pottala, J. V., Lacey, S. M., Vasan, R. S., Larson, M. G., & Robins, S. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.030 · Cited by 150
“These may be secondary to effects of these fatty acids on heart rate [10], inflammation [11], endothelial function [12], serum lipid levels [13] and/or platelet function [14], which themselves may be mediated by changes in eicosanoid metabolism [15], membrane biophysics [16], and gene expression [17].”
BackgroundLee, C.-H., Fu, Y., Yang, S., & Chi, C. (2020) · Nutrients · doi:10.3390/nu12092769 · Cited by 148
“SDA is a metabolic intermediate in the transformation of α-ALA to EPA and DHA [26,27].”
BackgroundInfluentialComparison of bioavailability of krill oil versus fish oil and health effect
Ulven, S. M., & Holven, K. B. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s85165 · Cited by 133
Strandberg, T. E., Pitkälä, K. H., & Tilvis, R. S. (2011) · European Geriatric Medicine · doi:10.1016/j.eurger.2011.08.003 · Cited by 134
“Scattered studies are available of omega-3 fatty acids – which may be useful because of their antiinflammatory effects [139], and stimulation of muscle protein synthesis [140] – ghrelin mimetics [141], DHEAS [142], and creatine [97,143,144].”
BackgroundHayden, M. R. (2023) · Medicina · doi:10.3390/medicina59030561 · Cited by 131
Jones, P. J., Senanayake, V. K., Pu, S., Jenkins, D. J., Connelly, P. W., Lamarche, B., Couture, P., Charest, A., Baril-Gravel, L., West, S. G., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.081133 · Cited by 115
Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of Polyunsaturated Fatty Acids
Dessì, M., Noce, A., Bertucci, P., di Villahermosa, S. M., Zenobi, R., Castagnola, V., Addessi, E., & Daniele, N. D. (2013) · ISRN Inflammation · doi:10.1155/2013/191823 · Cited by 115
“Several, although not all, clinical trials have also found that consumption of n-3 PUFAs lowers circulating markers of endothelial dysfunction, such as Eselectin, vascular cell adhesion molecule-1, and intracellular adhesion molecule-1 [74, 112, 113].”
BackgroundEcheverría, F., Valenzuela, R., Espinosa, A., Bustamante, A., Álvarez, D., Gonzalez‐Mañán, D., Ortíz, M., Soto-Alarcón, S. A., & Videla, L. A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.09.012 · Cited by 108
Lapuente, M., Estruch, R., Shahbaz, M., & Casas, R. M. (2019) · Nutrients · doi:10.3390/nu11102381 · Cited by 113
“Several epidemiological studies (Table 1) have reported significant reductions of inflammatory biomarkers such as monocyte chemoattractant protein-1 (MCP-1) [50], vascular adhesion molecule 1 (VCAM-1) [51], IL-6, IL-8 and tumour necrosis factor (TNF)-α, after the intake of tomato juice [52].”
Backgroundω-3 fatty acids contribute to the asthma-protective effect of unprocessed cow's milk
Brick, T., Schober, Y., Böcking, C., Pekkanen, J., Genuneit, J., Loss, G. J., Dalphin, J., Riedler, J., Lauener, R. P., Nockher, W. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.042 · Cited by 104
Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids
Nording, M. L., Yang, J., Georgi, K., Hegedus Karbowski, C., German, J. B., Weiss, R. H., Hogg, R. J., Trygg, J., Hammock, B. D., & Zivkovic, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076575 · Cited by 100
ApoE genotype: from geographic distribution to function and responsiveness to dietary factors
Egert, S., Rimbach, G. H., & Huebbe, P. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000249 · Cited by 97
Valenzuela, R., & Videla, L. A. (2020) · Nutrients · doi:10.3390/nu12020499 · Cited by 97
Meijerink, J., Balvers, M. G. J., & Witkamp, R. F. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12030 · Cited by 94
“Benefits in humans seem to be most consistent for mortality from coronary heart disease and sudden cardiac death (Riediger et al., 2009; de Roos et al., 2009; De Caterina, 2011; Mozaffarian and Wu, 2011).”
BackgroundWachira, J. K., Larson, M. K., & Harris, W. S. (2014) · British Journal of Nutrition · doi:10.1017/s000711451300425x · Cited by 91
Impact of n − 3 fatty acids on endothelial function: results from human interventions studies
Egert, S., & Stehle, P. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283439622 · Cited by 90
Tiwari, A., Melchor-Martínez, E. M., Saxena, A., Kapoor, N., Singh, K. J., Saldarriaga-Hernández, S., Parra‐Saldívar, R., & Iqbal, H. M. N. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.219 · Cited by 92
Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient
Anez‐Bustillos, L., Dao, D. T., Baker, M. A., Fell, G. L., Puder, M., & Gura, K. M. (2016) · Nutrition in Clinical Practice · doi:10.1177/0884533616662996 · Cited by 94
Redefining essential fatty acids in the era of novel intravenous lipid emulsions
Anez‐Bustillos, L., Dao, D. T., Fell, G. L., Baker, M. A., Gura, K. M., Bistrian, B. R., & Puder, M. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.07.004 · Cited by 86
Tapia, G., Valenzuela, R., Espinosa, A., Pamela Romanque, U., Dossi, C. G., Gonzalez‐Mañán, D., Videla, L. A., & D’Espessailles, A. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300458 · Cited by 85
Siasos, G., Tousoulis, D., Oikonomou, E. K., Zaromitidou, M., Verveniotis, A., Plastiras, A., Kioufis, S., Maniatis, K., Miliou, A., Siasou, Z., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.10.081 · Cited by 84
Molecular Nutrition Research—The Modern Way Of Performing Nutritional Science
Norheim, F., Gjelstad, I., Hjorth, M., Vinknes, K., Langleite, T., Holen, T., Jensen, J., Dalen, K., Karlsen, A., Kielland, A., et al. (2012) · Nutrients · doi:10.3390/nu4121898 · Cited by 83
“Polyunsaturated FAs (PUFA) may influence proliferation of Thus, FAs may be important for regulation of gene transcription and thereby regulate metabolism, cell proliferation and cell death.”
BackgroundInfluentialHu, Q., Wei, B., Wei, L., Hua, K., Yu, X., Li, H., & Ji, H. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.152 · Cited by 81
Videla, L. A., & Pettinelli, P. (2012) · PPAR Research · doi:10.1155/2012/107434 · Cited by 79
Masson, S., Marchioli, R., Mozaffarian, D., Bernasconi, R., Milani, V., Dragani, L. K., Tacconi, M. T., Marfisi, R. M., Borgese, L., Cirrincione, V., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.10.021 · Cited by 73
Jiang, L., Wang, J., Xiong, K., Xu, L., Zhang, B., & Ma, A. (2021) · Nutrients · doi:10.3390/nu13072342 · Cited by 72
da Costa, E., Melo, T., Reis, M., Domingues, P., Calado, R., Abreu, M. H., & Domingues, M. R. (2021) · Marine Drugs · doi:10.3390/md19080414 · Cited by 66
Effenberger, K. E., Breyer, S., & Schobert, R. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.01.037 · Cited by 66
Echeverría, F., Valenzuela, R., Bustamante, A., Álvarez, D., Ortíz, M., Soto-Alarcón, S. A., Muñoz, P., Corbari, A., & Videla, L. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5109503 · Cited by 63
“liver, producingmetabolic products such asDHA, E-resolvins [38], epoxy-derivatives [39], and/or J3 isoprostanes [40], thus limiting the concentration needed for cell signaling.”
BackgroundMeijerink, J., Poland, M., Balvers, M. G. J., Plastina, P., Lute, C., Dwarkasing, J. T., van Norren, K., & Witkamp, R. F. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12747 · Cited by 63
“It is assumed that many of the health effects of n-3 LC-PUFAs are related to modulation or resolution of an elevated inflammatory status, which often plays a primary or secondary role in these disorders (de Roos et al., 2009; Calder, 2011; De Caterina, 2011).”
BackgroundGammelmark, A., Madsen, T., Varming, K., Lundbye‐Christensen, S., & Schmidt, E. B. (2012) · Nutrition Research · doi:10.1016/j.nutres.2011.12.007 · Cited by 63
“Several studies have reported that n-3 PUFA exerts antiinflammatory effects [33,34], but most studies used a relatively high dose of n-3 PUFA (N2 g/d) [9,34].”
BackgroundGarcía-Alonso, F. J., Jorge-Vidal, V., Ros, G., & Periago, M. J. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0225-0 · Cited by 63
“The n-3 PUFAs also have been reported to decrease triglyceride levels, platelet aggregation and adhesion, adiponectin levels, blood pressure, and heart rate, as well as levels of inflammation markers such as IL-6 and TNF-a [1, 9, 11, 12].”
BackgroundRehabilitation and acute exacerbations
Burtin, C., Decramer, M., Gosselink, R., Janssens, W., & Troosters, T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00079111 · Cited by 64
Posicionamento sobre o Consumo de Gorduras e Saúde Cardiovascular – 2021
Izar, M. C. D. O., Lottenberg, A. M., Giraldez, V. Z. R., Santos, R. D., Machado, R. M., Bertolami, A., Assad, M. H. V., Saraiva, J. F. K., Faludi, A. Á., Moreira, A. S. B., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201340 · Cited by 78
Egert, S., Baxheinrich, A., Lee-Barkey, Y. H., Tschoepe, D., Wahrburg, U., & Stratmann, B. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514002001 · Cited by 58
High-Resolution Lipidomics of the Early Life Stages of the Red Seaweed Porphyra dioica
da Costa, E. V., Azevedo, V., Melo, T., Rego, A. M., Evtuguin, D. V., Domingues, P. M., Calado, R., Pereira, R., Abreu, H., & Domingues, M. R. (2018) · Molecules · doi:10.3390/molecules23010187 · Cited by 55
“Many studies reported that supplementation with EPA contribute to reduce the risk of acute inflammatory response [40,41].”
BackgroundZúñiga‐Hernández, J., Venegas, F. C., Villarreal, M., Núñez, D., Chandia, M., Valenzuela, R., Tapia, G., Varela, P., Videla, L. A., & Fernández, V. (2010) · Free Radical Research · doi:10.3109/10715762.2010.485995 · Cited by 52
Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: Role of PPAR-α and SREBP-1c
Dossi, C. G., Tapia, G. S., Espinosa, A., Videla, L. A., & D'Espessailles, A. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.04.011 · Cited by 51
“Metabolism of n-3 LCPUFA generates several potent antiinflammatory mediators including (i) E-series and D-series of resolvins produced by the action of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) [47], (ii) 5-LOX-dependent protectin D1 production [48], (iii) 17S-hydroxy-DHA [14] and (iv) formation of epoxyeico…”
Backgroundn-3 polyunsaturated fatty acids and insulin secretion
Wang, X., & Chan, C. B. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0581 · Cited by 50
Kondo, K., Morino, K., Nishio, Y., Kondo, M., Nakao, K., Nakagawa, F., Ishikado, A., Sekine, O., Yoshizaki, T., Kashiwagi, A., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.005 · Cited by 49
“[15] de Roos B, Mavrommatis Y, Brouwer IA.”
BackgroundValenzuela, R., Espinosa, A., Llanos, P., Hernández‐Rodas, M. C., Barrera, C. R., Vergara, D., Romero, N., Pérez, F., Manuel Ruz, O., & Videla, L. A. (2015) · Food & Function · doi:10.1039/c5fo01086a · Cited by 45
Omega 3 and omega 6 fatty acids in human and animal health: An African perspective
Dunbar, B. S., Bosire, R., & Deckelbaum, R. J. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.10.009 · Cited by 43
“(adapted from de Roos et al., 2009) Please cite this article in press as: B.S. Dunbar, R.V. Bosire, R.J. Deckelbaum, Omega 3 and omega 6 fatty acids in human and animal health: An African perspective, Molecular and Cellular Endocrinology (2014), doi: 10.1016/j.mce.2014.10.009 Q4 Q5 Q6 1 2 3 4 5 6 7…”
InfluentialAbbasi, F., Samadi, F., Jafari, S. M., Ramezanpour, S. S., & Shargh, M. S. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.04.030 · Cited by 44
Burak, C., Wolffram, S., Zur, B., Langguth, P., Fimmers, R., Alteheld, B., Stehle, P., & Egert, S. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.012 · Cited by 42
Nutrients other than carbohydrates: their effects on glucose homeostasis in humans
Heer, M. A., & Egert, S. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2533 · Cited by 44
Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?
Serhiyenko, V. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.245 · Cited by 42
Egert, S., Lindenmeier, M., Harnack, K., Krome, K., Erbersdobler, H. F., Wahrburg, U., & Somoza, V. (2012) · Journal of Nutrition · doi:10.3945/jn.112.161802 · Cited by 41
Reynolds, C. M., Draper, E., Keogh, B., Rahman, A., MOLONEY, A. P., Mills, K. H. G., Loscher, C. E., & Roche, H. M. (2009) · Journal of Nutrition · doi:10.3945/jn.109.113035 · Cited by 39
Gong, Y., Lin, M., Piao, L., Li, X., Yang, F., Zhang, J., Xiao, B., Zhang, Q., Song, W., Yin, H., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12986 · Cited by 35
Mielczarek‐Puta, M., Struga, M., & Roszkowski, P. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02443-0 · Cited by 34
Fernández, V. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.119 · Cited by 33
McMurray, D. N., Bonilla, D. L., & Chapkin, R. S. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.07.003 · Cited by 32
Shijo, Y., Maruyama, C., Nakamura, E., Nakano, R., Shima, M., Mae, A., Okabe, Y., Park, S., Kameyama, N., & Hirai, S. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.43448 · Cited by 31
Egert, S., Baxheinrich, A., Lee-Barkey, Y. H., Tschoepe, D., Stehle, P., Stratmann, B., & Wahrburg, U. (2017) · Nutrition · doi:10.1016/j.nut.2017.11.002 · Cited by 31
Tyrode, E. C., Niga, P., Johnson, M., & Rutland, M. W. (2010) · Langmuir · doi:10.1021/la102189z · Cited by 27
Mavrommatis, Y., Ross, K., Rucklidge, G. J., Reid, M., Duncan, G., Gordon, M., Thiès, F., Sneddon, A. A., & de Roos, B. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991450 · Cited by 24
Self-citationDietary Fat and Blood Pressure
Nestel, P. J. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0918-y · Cited by 24
Dossi, C. G., Gonzalez‐Mañán, D., Romero, N., Silva, D., Videla, L. A., & Tapia, G. (2018) · Food & Function · doi:10.1039/c8fo00969d · Cited by 20
Park, I., Xun, P., Tsinovoi, C. L., Klemmer, P. J., Liu, K., & He, K. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02022-4 · Cited by 20
Diabetic Cardiac Autonomic Neuropathy
Serhiyenko, V. A., & Serhiyenko, A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_57 · Cited by 26
Guo, L., Chang, Y., Sun, Z., Deng, J., Jin, Y., Shi, M., Zhang, J., & Miao, Z. (2023) · Foods · doi:10.3390/foods12071479 · Cited by 19
“Furthermore, EPA and DHA have anti-inflammatory or anti-inflammatory properties, whereas SFAs are the opposite [52,53].”
BackgroundAugimeri, G., Plastina, P., Gionfriddo, G., Rovito, D., Giordano, C., Fazio, A., Barone, I., Catalano, S., Andò, S., Bonofiglio, D., et al. (2019) · Nutrients · doi:10.3390/nu11092247 · Cited by 19
Maruyama, C., Shijo, Y., Kameyama, N., Umezawa, A., Sato, A., Nishitani, A., Ayaori, M., Ikewaki, K., Waki, M., & Teramoto, T. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.60376 · Cited by 23
Dietary Omega-3 Fatty Acid Intake and Mortality in CKD Population: A 1999–2014 NHANES Analysis
Li, W.-L., Zhang, N.-H., Ge, S.-W., & Xu, G. (2021) · American Journal of Nephrology · doi:10.1159/000520027 · Cited by 16
Diabetic Cardiac Autonomic Neuropathy
Serhiyenko, V. A., & Serhiyenko, A. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_53 · Cited by 18
n-3 PUFA Improve Emotion and Cognition during Menopause: A Systematic Review
Decandia, D., Landolfo, E., Sacchetti, S., Gelfo, F., Petrosini, L., & Cutuli, D. (2022) · Nutrients · doi:10.3390/nu14091982 · Cited by 18
“ALA is the largest dietary source of n-3 PUFA [42] but, since it cannot be endogenously synthesized by humans, it must be obtained from plant sources, such as flaxseeds, cranberry seeds, walnuts, almonds, nuts, kiwi seeds, canola oil, soybeans, and chia seeds [43].”
BackgroundFatty acids and epigenetics in health and diseases
Chung, M.-Y., & Kim, B. H. (2024) · Food Science and Biotechnology · doi:10.1007/s10068-024-01664-3 · Cited by 21
“Monounsaturated FAs (MUFAs) contain at least 12 carbon atoms with single double bonds, whereas polyunsaturated FAs (PUFAs) have two or more double bonds (de Roos et al., 2009; Karapanagio-tidis et al., 2007).”
Oliva, M. E., Ingaramo, P. I., Joubert, M. B. V., Ferreira, M. D. R., & D’Alessandro, M. E. (2021) · Food & Function · doi:10.1039/d1fo02274a · Cited by 17
Tree peony transcription factor PrWRI1 enhances seed oil accumulation
Xie, L., Hu, J., Yan, Z., Li, X., Wei, S., Xu, R., Yang, W., Gu, H., & Zhang, Q. (2023) · BMC Plant Biology · doi:10.1186/s12870-023-04127-9 · Cited by 16
Change in Mononuclear Leukocyte Responsiveness in Midpregnancy and Subsequent Preterm Birth
Harper, M., Li, L., Zhao, Y., Klebanoff, M. A., Thorp, J. M., Sorokin, Y., Varner, M. W., Wapner, R. J., Caritis, S. N., Iams, J. D., et al. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182878a80 · Cited by 16
Endothelial cells as targets for chylomicron remnants.
Dalla-Riva, J., Garonna, E., Elliott, J., Botham, K., & Wheeler-Jones, C. (2010) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2010.04.001 · Cited by 14
n-3 Polyunsaturated fatty acids and mast cell activation
Wang, X., & Kulka, M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ru0814-388r · Cited by 16
Wu, S., Yang, K.-J., Liu, W., Malau, I. A., Zailani, H., Chang, C., Huang, S., Chang, J. P., Chiu, W., & Su, K. (2024) · Nutrients · doi:10.3390/nu16213688 · Cited by 19
He, B., Wang, Y., Dou, X., & Chen, Y. (2016) · Algal Research · doi:10.1016/j.algal.2016.10.007 · Cited by 15
Videla, L. A., Vargas, R., Valenzuela, R., Muñoz, P., Corbari, A., & Hernández‐Rodas, M. C. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.11.013 · Cited by 14
Videla, L. A. (2019) · IUBMB Life · doi:10.1002/iub.2067 · Cited by 13
Lee, C. C., & Adler, A. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0279-3 · Cited by 13
“Long-chain n-3 PUFAs may improve endothelial function by decreasing the production of inflammatory eicosanoids, cytokines, and endothelial adhesion molecules, as well as by increasing the synthesis of nitric oxide [42].”
Backgroundde Roos, B., Binacchi, F., Whybrow, S., & Sneddon, A. A. (2016) · Public Health Nutrition · doi:10.1017/s1368980016002688 · Cited by 13
Nutritional Lipidomics in Alzheimer’s Disease
Kalli, Ε. G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32633-3_14 · Cited by 11
Dietary Rosa mosqueta (Rosa rubiginosa) oil prevents high diet-induced hepatic steatosis in mice
D’Espessailles, A., Dossi, C. G., Espinosa, A., Gonzalez‐Mañán, D., & Tapia, G. (2015) · Food & Function · doi:10.1039/c5fo00741k · Cited by 11
Saboori, S., Djalali, M., Rad, E. Y., Nematipour, E., Saboor-Yaraghi, A. A., Javanbakht, M. H., Eshraghian, M. R., Ramezani, A., & Koohdani, F. (2016) · PubMed Central · Cited by 10
Anti-inflammatory and immunoregulatory effects of pinolenic acid in rheumatoid arthritis
Takala, R., Ramji, D. P., Andrews, R., Zhou, Y., Burston, J. J., & Choy, E. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab467 · Cited by 10
“Data from large observational studies on cardiovascular diseases support the efficacy of n -3 PUFAs, mainly EPA and DHA, to prevent inflammation by lowering the blood levels of IL-6, TNF-a and CRP [10].”
Fats in Human Milk: 2022 Updates on Chemical Composition
Maheshwari, A. (2022) · Newborn · doi:10.5005/jp-journals-11002-0050 · Cited by 9
Magisetty, J., Gadiraju, B., & Kondreddy, V. K. R. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128867 · Cited by 9
de Roos, B., & Romagnolo, D. F. (2012) · Journal of Nutrition · doi:10.3945/jn.111.157206 · Cited by 8
“, cancer and inflammation) (15), there is a growing interest in developing protein biomarkers related to the efficacy of fatty acids.”
BackgroundInfluentialdo Vale, M. R. L., Buckner, L., Mitrofan, C. G., Tramontt, C. R., Kargbo, S. K., Khalid, A., Ashraf, S., Mouti, S., Dai, X., Unwin, D., et al. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000378 · Cited by 7
Promising Functional Lipids for Therapeutic Applications
Paul, D., Dey, T. K., Chakraborty, A., & Dhar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811448-3.00013-9 · Cited by 7
Dey, T. K., Bose, P., Paul, S., Karmakar, B. C., Saha, R. N., Gope, A., Koley, H., Ghosh, A., Dutta, S., Dhar, P., et al. (2022) · Food & Function · doi:10.1039/d1fo04419b · Cited by 7
Ácidos grasos poliinsaturados de cadena larga ω-3 y enfermedad cardiovascular
Rodrigo Valenzuela, B., Morales, G. I., Marcela González, A., Jessica Morales, P., Julio Sanhueza, C., & Alfonso Valenzuela, B. (2014) · Revista chilena de nutrición · doi:10.4067/s0717-75182014000300014 · Cited by 8
Metadata
- Authors
- de Roos, B., Mavrommatis, Y., & Brouwer, I. A.
- Affiliations
- University of Aberdeen (GB)
- Vrije Universiteit Amsterdam (NL)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2009-08-28
- Volume
- 158
- Issue
- 2
- Pages
- 413-428
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2757681
- OpenAlex
- W2148516429
- Cited by
- 151
- References
- 209
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 11 · 2020: 4 · 2019: 12 · 2018: 11 · 2017: 5 · 2016: 12 · 2015: 10 · 2014: 17 · 2013: 10 · 2012: 18
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Scottish Government
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Keywords
- n-3 long-chain polyunsaturated fatty acids, omega-3 fatty acids, coronary artery disease, inflammation, inflammation resolution, endothelial activation, eicosanoid metabolism, triglycerides, cardiac arrhythmias, platelet aggregation, biomarkers of inflammation, cardiovascular risk
- MeSH terms
- Animals, Clinical Trials as Topic, Coronary Disease, Dose-Response Relationship, Drug, Humans, Inflammation, Biomarkers, Fatty Acids, Omega-3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review